(Q43273800)

18 November 2017

1 reference

title

Effects of dietary bioactive compounds on obesity induced inflammation (English)

1 reference

18 November 2017

0 references

0 references

Deborah H M Bastos

1

1 reference

18 November 2017

Marcelo M Rogero

series ordinal

2

1 reference

18 November 2017

José Alfredo G Arêas

series ordinal

3

1 reference

18 November 2017

language of work or name

Portuguese

0 references

publication date

1 July 2009

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

18 November 2017

1 reference

18 November 2017

53

1 reference

18 November 2017

5

1 reference

18 November 2017

646-656

1 reference

Dietary management of the metabolic syndrome beyond macronutrients

18 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Dietary reference intake (DRI) value for dietary polyphenols: are we heading in the right direction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Nutritional characteristics of wild primate foods: do the diets of our closest living relatives have lessons for us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Effects of a short-term intervention with a paleolithic diet in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Inflammation, obesity and comorbidities: the role of diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Adipose inflammation, insulin resistance, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Obesity-induced inflammation: a metabolic dialogue in the language of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Obesity, inflammation, and the potential application of pharmaconutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Dietary glutamine supplementation affects macrophage function, hematopoiesis and nutritional status in early weaned mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Regulation of inflammation and redox signaling by dietary polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Integration of metabolism and inflammation by lipid-activated nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

PPARalpha and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Effects of caffeoyl conjugates of isoprenyl-hydroquinone glucoside and quinic acid on leukocyte function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

NF-kappaB in liver diseases: a target for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Chlorogenic acid protects paraoxonase 1 activity in high density lipoprotein from inactivation caused by physiological concentrations of hypochlorite

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by suppressing NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Biotransformation of green tea polyphenols and the biological activities of those metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Cancer chemopreventive activity and bioavailability of tea and tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Inhibition of carcinogenesis by tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Bioavailability of phenolic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Novel biomarkers of the metabolism of caffeic acid derivatives in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000500017

10.1590/S0004-27302009000500017

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference